Primer extension provides a functional readout of telomerase activity rather than simply indicating that telomerase-related material is present. When telomerase adds repetitive telomeric DNA sequences to the primer, the assay captures that enzymatic capability. This matters in cancer research because sustained telomere-supporting activity is associated with continued cellular lifespan and tumor biology.
The telomeric repeat amplification protocol links enzymatic extension to signal generation in two stages. First, telomerase extends a primer by adding repetitive DNA sequences. The resulting products are then amplified, making the activity easier to detect and compare across samples. This design converts a molecular extension event into a measurable assay output.
Both detection approaches identify products generated after primer extension and amplification, but they present the results differently. Fluorescence provides a signal-based readout, whereas gel electrophoresis displays amplified products as separated bands. Choosing between them affects how researchers examine assay results, while the underlying measurement remains telomerase-dependent product formation.
Cancer cells frequently reactivate telomerase, connecting this activity with the ability to support extended cellular lifespan. Measuring the activity therefore helps investigators examine a feature related to replicative immortality and tumor biology. The assay can distinguish activity patterns among cancer-related samples, creating a functional basis for studying how telomerase contributes to malignancy.
A typical workflow begins by applying the assay to the selected biological samples, allowing telomerase to extend the assay primer, and then amplifying the resulting repetitive DNA products. Researchers detect those products through fluorescence or gel electrophoresis and compare the resulting signals or patterns among tumors, cultured cells, or treatment conditions.
Researchers can use a Telomerase Activity Assay when they want to compare telomerase activity before and after a treatment or across different treatment conditions. Changes in the assay readout provide information about how the treatment relates to telomerase function. This supports investigation of potential responses to therapies designed to target telomerase.